Try our beta test site
2 studies found for:    Kersten Waldenstrom's
Show Display Options
Rank Status Study
1 Recruiting Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's Macroglobulinemia
Condition: Waldenström's Macroglobulinemia
Interventions: Drug: Dexamethasone, Rituximab, Cyclophosphamide;   Drug: Dexamethasone, Rituximab, Cyclophosphamide, Bortezomib
2 Recruiting A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM)
Condition: Waldenström's Macroglobulinemia
Interventions: Drug: BGB-3111;   Drug: Ibrutinib

Study has passed its completion date and status has not been verified in more than two years.